MedPath

Tianjin Central Hospital Gynecology Obstetrics

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Early Prediction of Gestational Diabetes in High-risk Women Based on Breath Metabolomics

Conditions
Gestational Diabetes
First Posted Date
2024-12-31
Last Posted Date
2025-05-31
Lead Sponsor
Tianjin Central Hospital of Gynecology Obstetrics
Target Recruit Count
600
Registration Number
NCT06753734
Locations
🇨🇳

Tianjin Central Hospital of Gynecology Obstetrics, Tianjin, China

The Relationship Between Fetal Membrane Thickness and Fetal Chromosomal Aneuploidies

Recruiting
Conditions
Chromosome Aberrations
First Posted Date
2023-11-21
Last Posted Date
2023-11-21
Lead Sponsor
Tianjin Central Hospital of Gynecology Obstetrics
Target Recruit Count
300
Registration Number
NCT06141213
Locations
🇨🇳

Tianjin Central Hospital of Obstetrics and Gynecology, Tianjin, Tianjin, China

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.